A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.
Lenacapavir offers key HIV treatment advances
Original Article by Kat Lay | The Guardian | 26 July 2024
A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...